Supernus Pharmaceuticals, Inc. Ratios

Ratios Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 90.81%93.79%94.29%94.43%94.97%96.24%95.76%89.92%87.05%86.93%86.21%88.23%
EBT Margin -37,239.62%-4,915.32%-3,127.30%-767.73%-11.11%9.91%23.43%33.29%34.28%37.55%32.41%12.62%9.10%0.46%14.79%
EBIT Margin -37,851.89%-4,701.37%-2,849.26%-515.18%-5.69%14.13%25.22%32.93%35.33%37.83%33.38%14.84%6.91%-0.87%12.34%
EBITDA Margin -37,851.89%-4,701.37%-2,849.26%-515.18%-5.69%14.13%25.22%32.93%35.33%37.83%33.38%14.84%6.91%-0.87%12.34%
Operating Margin -37,851.89%-4,701.37%-2,849.26%-515.18%-5.69%14.13%25.22%32.93%35.33%37.83%33.38%14.84%6.91%-0.87%12.34%
Net Margin -39,521.70%6,274.60%-3,204.53%-767.73%21.44%9.46%42.43%18.95%27.14%28.79%24.39%9.21%9.10%0.22%11.16%
FCF Margin -30,979.25%-4,843.21%-3,240.00%-495.84%-27.07%21.98%30.33%37.26%31.34%35.75%25.93%21.93%17.45%18.19%25.87%
Efficiency
Inventory Average 4.15M10.30M13.01M14.69M16.55M20.98M26.14M37.48M67.14M88.75M84.47M65.85M
Assets Average 73.86M102.49M123.89M162.71M249.10M367.02M701.14M1,069.05M1,332.19M1,596.63M1,695.83M1,490.09M1,322.87M
Equity Average -17.44M33.51M45.52M37.08M64.35M139.88M230.78M361.41M524.23M670.14M780.35M851.03M903.86M978.62M
Invested Capital -44.32M16.22M69.38M33.46M40.70M88.01M191.75M269.80M855.52M595.43M775.76M1,195.10M907.32M973.59M1,083.07M
Asset Utilization Ratio 0.020.120.750.910.860.820.580.370.390.360.390.410.50
Leverage & Solvency
Interest Coverage Ratio -20.23-11.80-7.89-1.0616.9699.8563.487.986.547.313.676.52-2.18
Debt to Equity 3.120.400.040.520.020.060.05
Debt Ratio 0.550.240.020.250.010.040.03
Equity Ratio 0.180.610.300.300.470.620.640.460.510.500.480.520.720.76
Times Interest Earned -20.23-11.80-7.89-1.0616.9699.8563.487.986.547.313.676.52-2.18
Valuation
Enterprise Value -23.74M-48.54M87.37M172.99M281.99M595.34M1,159.97M1,902.76M1,379.96M897.35M903.02M1,211.07M1,466.92M1,326.20M1,543.12M
Market Capitalization 175.88M255.18M356.32M657.53M1,250.09M2,042.80M1,735.98M1,244.42M1,325.56M1,550.75M1,928.25M1,581.07M1,996.73M
Return Ratios
Return on Sales 5.77%95.94%-31.27%-7.68%-0.12%0.09%0.42%0.19%0.27%0.29%0.24%0.09%0.09%0.00%0.11%
Return on Capital Employed -0.83%-0.81%-0.06%0.20%0.32%0.41%0.27%0.16%0.16%0.07%0.05%0.00%0.08%
Return on Invested Capital 1.58%0.31%0.25%0.20%0.16%0.19%0.06%0.04%0.00%0.06%
Return on Assets -0.63%-0.90%-0.09%0.09%0.37%0.16%0.16%0.11%0.10%0.03%0.04%0.00%0.06%
Return on Equity -4.42%-1.38%-2.03%-0.29%0.22%0.65%0.25%0.31%0.22%0.19%0.07%0.07%0.00%0.08%